Dissolution testing system DTG 200i-IS

for tabletsfor coatingfor pharmaceutical applications

The result of decades of innovation and experience in the field of pharmaceutical testing, the DTGi Series of disintegration testers from Copley simplifies testing within R&D and QC environments. Suitable for a wide range of tablet and capsule types (e.g. plain-coated tablets, delayed-release, gelatine etc.), the DTGi tester series is an affordable range of disintegration testers that complies fully with specifications defined in Ph. Eur., USP and associated Pharmacopoeias. With the same standard features as the other DTGi Series testers and supporting up to 2 basket rack assemblies, the DTG 200i-IS offers independent control over each test station, making it ideal for the following types of applications: Comparing one formulation directly against another Comparing the performance of a single formulation under different conditions Assessing delayed release or enteric coated tablets where samples must be immersed for specified periods of time in different media Allowing two users to run tests simultaneously Pharmacopoeial Compliance: Ph. Eur. 2.9.1 USP and Number of Test Stations: 2 2 Up to 12 Independent Station Control: Yes Unit Dimensions (w x d x h): 515 x 473 x 657 mm Key DTGi Series Highlights Ph. Eur. and USP and compliant Integrated, precision temperature control and measurement Single-point electronic temperature calibration Intuitive touchscreen control to simplify operation One to four test station unit configurations, plus independent station control unit option Extensive data reporting output options: RS 232, USB A and USB B Adjustable stroke frequency control for accelerated or high sensitivity testing